Real-world cost avoidance associated with bevacizumab biosimilar adoption in a tertiary public hospital in Ecuador: a cost-minimization and budget impact analysis.

Alymsys (bevacizumab-maly) - Amneal, Pharmaceutical Libbs, Nichi-Iko, Stada, mAbxience

http://www.ncbi.nlm.nih.gov/pubmed/42432665

Carla Arias; Carol Moreno; David Armas; María Del Carmen Aynaguano; Sara Rodríguez

Jul 11, 2026